Related Experiment Video
Updated: Jan 12, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Growing Up with HIV: A Comprehensive Review of Treatment and Care in Low- and Middle-Income Countries
Brigid E O'Brien1,2, Elizabeth Maidl3,4, Jacob L Todd3,5
1Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. Brigid.o'brien@bcm.edu.
Insights
Children and adolescents living with HIV (CALHIV) face unique challenges in low- and middle-income countries, including limited treatment options and emerging drug resistance. New, child-friendly therapies are crucial to improve care and meet global targets.
Area of Science:
- Pediatric infectious diseases
- HIV/AIDS research
- Global health
Background:
- Despite progress, children and adolescents living with HIV (CALHIV) encounter significant barriers to comprehensive care.
- Limited treatment options, psychosocial challenges, and caregiver dependence hinder effective management in low- and middle-income countries (LMIC).
Purpose of the Study:
- To review the current state of care for CALHIV in LMIC.
- To identify challenges and unmet needs in pediatric HIV treatment.
- To highlight the importance of child-friendly treatment options and addressing HIV drug resistance.
Main Methods:
- Review of current literature on pediatric HIV care.
- Analysis of treatment guidelines and emerging resistance patterns.
- Assessment of global targets and treatment gaps for CALHIV.
Main Results:
- CALHIV are not meeting global UNAIDS targets compared to adults.
- Pre-treatment and acquired HIV drug resistance are more prevalent in CALHIV.
- Novel pediatric fixed-dose combinations (FDC) like abacavir/lamivudine/dolutegravir (ABC/3TC/DTG) show promise, but alternatives are needed.
Conclusions:
- Increased availability of child and adolescent-friendly treatment options is essential for lifelong comprehensive care.
- Expanded research and access to novel therapies are critical to close treatment gaps and combat emerging HIV drug resistance in CALHIV.
- Addressing unique developmental needs and vulnerabilities is key to successful pediatric HIV management.
Purpose Of Review:
Despite declining numbers of new pediatric HIV infections and advancements in treatment for children and adolescents living with HIV (CALHIV), barriers remain. Comprehensive care for CALHIV in low- and middle-income countries is challenged by limited treatment options, unique psychosocial challenges, and caregiver reliance. Successful care relies on understanding the unique developmental needs, as well as their vulnerabilities to treatment failure and HIV drug resistance.
Recent Findings:
CALHIV lag behind adults in meeting global UNAIDS targets. Increasing availability of pediatric fixed dose combinations (FDC) of abacavir/lamivudine/dolutegravir (ABC/3TC/DTG) may address some challenges but providing alternatives should be prioritized. Emerging evidence has demonstrated pre-treatment and acquired HIV drug resistance (HIVDR) are more prevalent in CALHIV. While novel therapies are in development, access remains a concern. Increased child and adolescent-friendly treatment options are needed to provide quality life-long comprehensive care to CALHIV in low- and middle-income countries (LMIC). Expanded research and access to novel therapies is key to close treatment gaps between CALHIV and their adult counterparts and address emerging HIV drug resistance.
Related Concept Videos
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Sexually Transmitted Infections
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...

